Dr. Onda-Tabita Calugaru

Competente in:

• Anomalii cromozomiale
• Boli multifactoriale
• Boli neurologice
• Cardiogenetica
• Hematogenetica
• Malformatii congenitale
• Oncogenetica
• Sindroame de dizabilitate intelectuala
• Sindroame metabolice

Membru in:

• European Hematology Association (EHA)
• European Society of Human Genetics (ESHG)
• Societatea Romana de Hematologie (SRH)
• Societatea Romana de Genetica Medicala (SRGM)
• Colegiul Medicilor Bucuresti (CMB)

• 2019 - 2021: Master stiintific „Genetica aplicata si biotehnologie”, Universitatea din Bucuresti, Facultatea de Biologie, Catedra de Genetica, Bucuresti

Cursuri postuniversitare:

• 2023: Update in Molecular Diagnosis of Acute Leukemias, Spitalul Clinic Fundeni, Bucuresti
• 2022: Molecular Biology in Hematological Diseases: from theory to practice, Spitalul Clinic Fundeni, Bucuresti

• 2023: Advantages in molecular characterization for precision oncology – Highlights from ClinGen Somatic Cancer and VICC Virtual Molecular Tumor Board Case Series, American College of Medical Genetics and Genomics
• 2023: ClinGen Somatic Cancer and VICC Virtual Molecular Tumor Board Case Series - On Demand, American College of Medical Genetics and Genomics
• 2023: Evidence Based Guidelines Webinar 101: Exome and Genome Sequencing For Pediatric Patients with Congenital Anomalies or Intellectual Disability - On Demand, American College of Medical Genetics and Genomics
• 2023: Introduction to MPNs, The European Hematology Association
• 2021: "Hereditary Heart Diseases", Online Course
• 2021: "Improving the professional skills of the medical staff involved in performing the medical act from relevant specialties for the multidisciplinary management of RARE GENETIC diseases" (PROGENERATION)
• 2020: "Virtual Flow-Cytometry School", Romanian Cytometry Association, Online course
• 2020: "Rare Diseases and Precision Genetic Diagnosis"
• 2020: "Improving the professional skills of the medical staff involved in performing the medical act from relevant specialties for the multidisciplinary management of RARE GENETIC diseases" (PROGENERATION)
• 2020: "Integrated Applied Genetics Training - AppGENEdu", UMF "Carol Davila", Bucuresti (Romania) and "Reykjavik University", Reykjavik
• 2019: "24 Days of Stem Cells virtual event", Thermo Fisher Scientific

Distinctii si premii: 

• Premiul III: Young Investigator Forum Meeting - Elena Avram, Onda Tabita Calugaru, poster "Inherited ophthalmic diseases in the European Union - state of the art in 2023", 14th International Congress of Human Genetics, Cape Town, Africa
• Cel mai bun poster al conferintei - National Congress of Hematology, XXVIII Edition, Sinaia, Romania, Onda Tabita Calugaru, Mihaela Dragomir, Cerasela Jardan, Silvia Aposteanu, Ana-Maria Mihalache, Georgiana Sotica, Daniel Coriu, "The importance of hsa-mir-4328 gene mutations in Acute Promyelocytic Leukemia

• Alexandra, G.; Doran, C.; Ionescu, B.; Stancioaica, M.C.; Hirjan, R.; Tatic, A.; Cirstea, M.; Dragomir, M.; Calugaru, O.; Popa, C.; Jardan, C.; Vasilache, D.; Coriu, D. Early Complications in the Era of ATRA Plus ATO Therapy Outside of Clinical Trials‐One Center Experience during Three Years and Literature Review. Preprints 2023, 2023080936. https://doi.org/10.20944/preprints202308.0936.v1
• Lupu OT, Popescu B, Avram E, Dragomir M, Cimponeriu G, Mighiu I, Aposteanu S, Coriu D. Downregulation of hsa-miR-4328 and target gene prediction in Acute Promyelocytic Leukemia. Revista Romana de Medicina de Laborator. 2022;30(3): 261-272. https://doi.org/10.2478/rrlm-2022-0022
• Calugaru O, Dragomir M, Aposteanu S, Jardan C, Meirosu AC, Coriu D. The importance of MIR-4328 gene mutations in Acute Promyelocytic Leukemia. Documenta Haematologica. 2023;1(2):37–41. http://doi.org/10.59854/dhrrh.2023.1.2.37
• Duca AM, Calugaru O, Cimponeriu D, Dragomir M, Aposteanu S, Coriu D, Crisan M, Iordache I, Mihailescu P, Gradinaru A, Ipate A, Stoica I. Torque teno viruses implications on chronic myeloid leukemia. Romanian Biotechnological Letters. 2023, 27(6):3787-3795. https://doi.org/10.25083/rbl/27.6/3787.3795
• Shelby ES, Lupu OT, Axente M, Leanca MC, Badina M, Padure L, Mirea A, Pelttari LM. New VOUS in CASK Gene Correlating with the MICPCH Phenotype. Maedica (Bucur). 2021 Mar;16(1):135-139. doi: 10.26574/maedica.2020.16.1.135. PMID: 34221169; PMCID: PMC8224713